Privia Health Group, Inc. $PRVA Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC grew its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 102.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 46,574 shares of the company’s stock after purchasing an additional 23,550 shares during the quarter. SG Americas Securities LLC’s holdings in Privia Health Group were worth $958,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Royal Bank of Canada raised its holdings in shares of Privia Health Group by 63.5% during the 1st quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock valued at $5,514,000 after buying an additional 95,371 shares during the period. AQR Capital Management LLC boosted its holdings in Privia Health Group by 24.7% in the 1st quarter. AQR Capital Management LLC now owns 40,781 shares of the company’s stock worth $916,000 after acquiring an additional 8,068 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Privia Health Group by 3.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 118,764 shares of the company’s stock valued at $2,666,000 after acquiring an additional 3,714 shares in the last quarter. Intech Investment Management LLC grew its position in Privia Health Group by 55.1% in the first quarter. Intech Investment Management LLC now owns 56,553 shares of the company’s stock valued at $1,270,000 after acquiring an additional 20,082 shares in the last quarter. Finally, Acadian Asset Management LLC purchased a new stake in shares of Privia Health Group during the first quarter valued at approximately $154,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Price Performance

PRVA stock opened at $27.36 on Friday. The stock’s 50 day moving average is $23.45 and its two-hundred day moving average is $23.02. Privia Health Group, Inc. has a 52-week low of $18.77 and a 52-week high of $27.52. The company has a market capitalization of $3.45 billion, a PE ratio of 171.01, a P/E/G ratio of 2.16 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last released its earnings results on Thursday, May 7th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.08 by $0.11. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.The company had revenue of $603.85 million during the quarter, compared to analysts’ expectations of $560.99 million. During the same period in the prior year, the business posted $0.22 EPS. The business’s revenue was up 25.8% on a year-over-year basis. As a group, sell-side analysts anticipate that Privia Health Group, Inc. will post 0.27 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Weiss Ratings raised shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday. Evercore set a $26.00 price target on shares of Privia Health Group in a report on Wednesday, April 8th. Barclays dropped their price target on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Finally, Canaccord Genuity Group cut their price objective on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $31.15.

Insider Activity at Privia Health Group

In other news, CFO David Mountcastle sold 17,196 shares of the business’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $25.18, for a total value of $432,995.28. Following the completion of the sale, the chief financial officer owned 211,462 shares of the company’s stock, valued at approximately $5,324,613.16. The trade was a 7.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Parth Mehrotra sold 15,647 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $22.64, for a total transaction of $354,248.08. Following the completion of the sale, the chief executive officer directly owned 434,357 shares of the company’s stock, valued at $9,833,842.48. The trade was a 3.48% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 319,487 shares of company stock valued at $7,736,834 over the last ninety days. Corporate insiders own 5.70% of the company’s stock.

Privia Health Group Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.